The American Society for Clinical Investigation (ASCI) publishes JCI Insight. The opinions expressed in JCI Insight are solely those of the authors and are not necessarily endorsed by the ASCI.
JCI Insight is an open access journal. All research content is freely available immediately upon publication, and all articles published in JCI Insight are deposited in PubMed Central (PMC). Users are allowed to read, download, print, search, or link to the full texts of the articles under the "fair use" limitations of US copyright law.
JCI Insight is fully compliant with the National Institutes of Health Public Access Policy. Authors of articles published in JCI Insight do not need to deposit their articles separately in PubMed or PMC. The Journal is also compliant with policies of other major funding sources, including Wellcome.
The ASCI retains copyright to most articles published in the JCI Insight. Permission to use figures or republish any JCI Insight content can be obtained via Copyright Clearance Center.
Some articles published in JCI Insight use the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Articles using this license are clearly marked. Readers wishing to reproduce content from such articles should follow the guidelines of the CC-BY 4.0 license.
Please see the "Download citation information" link under "Article Tools" for each article for guidance on proper citation format. For example, see this citation page for the JCI Insight article Histone deacetylase inhibitor panobinostat induces calcineurin degradation in multiple myeloma.
Users of JCI Insight have the right to read, download, print, search, or link to the full texts of these articles. Use of JCI Insight constitutes an agreement to comply with this and the following terms. Any copies, in whole or in part, must include the copyright notice or associated license information. Reproduction of material presented in the journal is governed by the "fair use" limitations of US copyright law (detailed at http://www.loc.gov/copyright/title17/).
In no event shall JCI Insight or the ASCI be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use of or reliance on this information. This publication is provided "as is" without warranty of any kind, either expressed or implied, including, but not limited to, the implied warranties of merchantability, fitness for a particular purpose, or non-infringement. Changes in policy or publication may be made at any time. Descriptions of, or references to, products or publications does not imply endorsement of that product or publication.